Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Lumen Technologies Inc (LUMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Lumen Technologies Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Lumen Technologies Inc trades at $4.49 (market cap $5.14B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Lumen Technologies Inc is more actively traded (15,538,010 versus 2,977,440). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Lumen Technologies Inc for 40 Days on average.
| IONS | LUMN | |
|---|---|---|
Market Cap | $7.04B | $5.14B |
Volume | 2,977,440 | 15,538,010 |
Sector | Health | Media |
52-Week High | $86.50 | $11.83 |
52-Week Low | $42.38 | $4.55 |
Typical Hold Time | 0 Days | 40 Days |
Enterprise Value | $6.60B | $16.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LUMN stock trades at $4.55, down 9.9% in the past 24 hours, reflecting bearish technical signals and negative investor sentiment. The company reported mixed quarterly earnings, with a Q1 2026 miss but a Q2 2026 beat, while full-year 2025 revenue declined to $12.40B with a net loss of $1.74B. High debt levels and a negative ROE of -78.94% highlight financial strain, though recent strategic moves include a Nasdaq listing and new AI-focused networking services to drive growth.
The outlook remains challenging due to persistent losses and heavy debt, but deep value metrics like a low P/S of 0.42 and strategic pivots to AI connectivity offer speculative upside. Key risks include execution on growth initiatives, competitive pressures, and interest rate sensitivity. Analysts are largely cautious, with a 'Reduce' consensus, suggesting limited near-term catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →
